GRAIL (GRAL) Stock: Buy, Sell, or Hold?
GRAL - GRAIL, Inc. Common Stock
$132.56
-7.56 (-5.40%)
▼
5d:
+5.87%
30d:
+67.02%
90d:
+94.63%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Sep 18, 2026 at $80.77 · last confirmed Sep 28, 2026
Strength: 6.5/10
Get Alerted When GRAL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: GRAL is 14.1% above its trading range ($116.19). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: GRAL is 14.1% above its trading range ($116.19). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: GRAL is currently trading at $132.56, which is considered extended relative to its 30-day fair value range of $70.19 to $116.19.
Technical Outlook: Technically, GRAL is in a uptrend. Immediate support is located at $75.29, while resistance sits at $151.46. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: GRAL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $97.40. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GRAL is in a uptrend. Immediate support is located at $75.29, while resistance sits at $151.46. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: GRAL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $97.40. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$70.19 -
$116.19
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
0.0%
Protect Your Profits
GRAL is technically overbought (RSI 84). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+14.1% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BEARISH: Trading 26.5% above Wall St target ($97.40)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$70.19 -
$116.19
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$75.29
Resistance Level
$151.46
Current Trend
Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.91
Wall Street Target
$97.40
(-26.5%)
Revenue Growth (YoY)
25.7%
Profit Margin
-236.9%
Share & Embed Analysis
Last updated: October 01, 2026 6:21 PM ET
Data refreshes hourly during market hours. Next update: 7:21 PM
Data refreshes hourly during market hours. Next update: 7:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRAL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua J Ofman
SELL
61665 shares
2026-04-08
Robert P Ragusa
SELL
123502 shares
2026-04-08
Aaron Freidin
SELL
45806 shares
2026-04-08
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 43 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 48 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 46 HOLD |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$345 | 65 BUY |
Advanced GRAL Option Strategies
Professional options setups generated by AI based on today's GRAL price and gamma walls.
